These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 12206878)
1. Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy. Borowski P; Schalinski S; Schmitz H Antiviral Res; 2002 Sep; 55(3):397-412. PubMed ID: 12206878 [TBL] [Abstract][Full Text] [Related]
2. NTPase/helicase of Flaviviridae: inhibitors and inhibition of the enzyme. Borowski P; Niebuhr A; Schmitz H; Hosmane RS; Bretner M; Siwecka MA; Kulikowski T Acta Biochim Pol; 2002; 49(3):597-614. PubMed ID: 12422230 [TBL] [Abstract][Full Text] [Related]
3. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses. Borowski P; Deinert J; Schalinski S; Bretner M; Ginalski K; Kulikowski T; Shugar D Eur J Biochem; 2003 Apr; 270(8):1645-53. PubMed ID: 12694177 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the helicase activity of HCV NTPase/helicase by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide-5 '-triphosphate (ribavirin-TP). Borowski P; Lang M; Niebuhr A; Haag A; Schmitz H; Schulze zur Wiesch J; Choe J; Siwecka MA; Kulikowski T Acta Biochim Pol; 2001; 48(3):739-44. PubMed ID: 11833782 [TBL] [Abstract][Full Text] [Related]
5. Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein. Wardell AD; Errington W; Ciaramella G; Merson J; McGarvey MJ J Gen Virol; 1999 Mar; 80 ( Pt 3)():701-709. PubMed ID: 10092010 [TBL] [Abstract][Full Text] [Related]
6. Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3. Zhong W; Ingravallo P; Wright-Minogue J; Skelton A; Uss AS; Chase R; Yao N; Lau JY; Hong Z Virology; 1999 Sep; 261(2):216-26. PubMed ID: 10497107 [TBL] [Abstract][Full Text] [Related]
7. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase. Borowski P; Lang M; Haag A; Baier A Antivir Chem Chemother; 2007; 18(2):103-9. PubMed ID: 17542155 [TBL] [Abstract][Full Text] [Related]
8. Towards defining a minimal functional domain for NTPase and RNA helicase activities of the hepatitis C virus NS3 protein. Kim DW; Gwack Y; Han JH; Choe J Virus Res; 1997 May; 49(1):17-25. PubMed ID: 9178493 [TBL] [Abstract][Full Text] [Related]
9. Characterization of imidazo[4,5-d]pyridazine nucleosides as modulators of unwinding reaction mediated by West Nile virus nucleoside triphosphatase/helicase: evidence for activity on the level of substrate and/or enzyme. Borowski P; Lang M; Haag A; Schmitz H; Choe J; Chen HM; Hosmane RS Antimicrob Agents Chemother; 2002 May; 46(5):1231-9. PubMed ID: 11959550 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. Suzich JA; Tamura JK; Palmer-Hill F; Warrener P; Grakoui A; Rice CM; Feinstone SM; Collett MS J Virol; 1993 Oct; 67(10):6152-8. PubMed ID: 8396675 [TBL] [Abstract][Full Text] [Related]
11. ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy. Borowski P; Mueller O; Niebuhr A; Kalitzky M; Hwang LH; Schmitz H; Siwecka MA; Kulikowsk T Acta Biochim Pol; 2000; 47(1):173-80. PubMed ID: 10961691 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus helicase/NTPase: an efficient expression system and new inhibitors. Mukovnya AV; Tunitskaya VL; Khandazhinskaya AL; Golubeva NA; Zakirova NF; Ivanov AV; Kukhanova MK; Kochetkov SN Biochemistry (Mosc); 2008 Jun; 73(6):660-8. PubMed ID: 18620531 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of the NTPase/helicases of hepatitis C and related Flaviviridae viruses. Bretner M; Najda A; PodwiĆska R; Baier A; Paruch K; Lipniacki A; Piasek A; Borowski P; Kulikowski T Acta Pol Pharm; 2004 Dec; 61 Suppl():26-8. PubMed ID: 15909930 [TBL] [Abstract][Full Text] [Related]
14. Helicase, a target for novel inhibitors of hepatitis C virus. Yao N; Weber PC Antivir Ther; 1998; 3(Suppl 3):93-7. PubMed ID: 10726059 [TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme. Borowski P; Niebuhr A; Mueller O; Bretner M; Felczak K; Kulikowski T; Schmitz H J Virol; 2001 Apr; 75(7):3220-9. PubMed ID: 11238848 [TBL] [Abstract][Full Text] [Related]
16. Allostery in the dengue virus NS3 helicase: Insights into the NTPase cycle from molecular simulations. Davidson RB; Hendrix J; Geiss BJ; McCullagh M PLoS Comput Biol; 2018 Apr; 14(4):e1006103. PubMed ID: 29659571 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step. Locatelli GA; Gosselin G; Spadari S; Maga G J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897 [TBL] [Abstract][Full Text] [Related]
18. Towards the design of flavivirus helicase/NTPase inhibitors: crystallographic and mutagenesis studies of the dengue virus NS3 helicase catalytic domain. Xu T; Sampath A; Chao A; Wen D; Nanao M; Luo D; Chene P; Vasudevan SG; Lescar J Novartis Found Symp; 2006; 277():87-97; discussion 97-101, 251-3. PubMed ID: 17319156 [TBL] [Abstract][Full Text] [Related]
19. Backbone 1H, 15N and 13C resonance assignments of the NTPase subdomain of the hepatitis C virus NS3 RNA helicase. Liu D; Wyss DF J Biomol NMR; 2001 Mar; 19(3):283-4. PubMed ID: 11330818 [No Abstract] [Full Text] [Related]
20. Analysis of the nucleoside triphosphatase, RNA triphosphatase, and unwinding activities of the helicase domain of dengue virus NS3 protein. Wang CC; Huang ZS; Chiang PL; Chen CT; Wu HN FEBS Lett; 2009 Feb; 583(4):691-6. PubMed ID: 19166847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]